AMC
AMC Entertainment Holdings, Inc.
AMC lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
PSO
Pearson plc
There isn't enough reported data to score PSO yet.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
PSO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate PSO's fundamentals.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
PSO PE Valuation
PSO has no meaningful PE right now: it lost money over the past year.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PSO Forward outlook
There aren't enough analyst estimates for PSO to show an outlook.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
PSO Earnings Per Share
PSO and AMC do not have enough comparable growth data to identify a winner.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over PSO in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over PSO on profitability, with a higher operating margin.
PSO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.4B | +4.1% |
| Q4 2025 | $2.5B | +2.5% |
| Q2 2025 | $2.3B | -1.8% |
| Q4 2024 | $2.4B | +0.2% |
| Q2 2024 | $2.3B | -6.7% |
| Q4 2023 | $2.4B | -13% |
| Q2 2023 | $2.5B | +5.1% |
| Q4 2022 | $2.7B | +12% |
PSO's revenue has slid since its 2013 peak: $2.4B last quarter, up 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +1.7 points |
| Q4 2025 | 15% | 0 points |
| Q2 2025 | 14% | +1.7 points |
| Q4 2024 | 18% | +5.2 points |
| Q2 2024 | 12% | +4.9 points |
| Q4 2023 | 15% | +9.2 points |
| Q2 2023 | 12% | +6 points |
| Q4 2022 | 13% | -3.3 points |
PSO's operating margin was 14% last quarter, up 1.7 points from the same quarter a year ago.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC's free cash flow has turned positive after six years mostly in the red: $168M over the past year.
PSO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $420.4M | +78% |
| Q4 2025 | $612.7M | +3.3% |
| Q2 2025 | $236.8M | +212% |
| Q4 2024 | $593.3M | -2.8% |
| Q2 2024 | $75.8M | +$129M |
| Q4 2023 | $610.6M | +28% |
| Q2 2023 | -$53.2M | +$18.6M |
| Q4 2022 | $476.2M | +17% |
PSO generated $1.9B in free cash flow over the past year, up 68% from the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
PSO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.4% | -28.3M shares |
| 1 year | -9.5% | -65M shares |
| 3 years | -18% | -137M shares |
| 5 years | -24% | -193M shares |
| Available history | -23% | -183M shares |
PSO has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $468.2M |
| Q4 2025 | $266.1M |
| Q2 2025 | $306M |
| Q4 2024 | $57.2M |
| Q2 2024 | $419M |
| Q4 2023 | $260.7M |
| Q2 2023 | $33.3M |
| Q4 2022 | $299.3M |
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
PSO Net Leverage
PSO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
PSO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 60.8 | Neutral |
PSO's weekly RSI is 59 (neutral) and its Stochastic is 61 (neutral).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
PSO PE vs Communication Services Sector
| Metric | PSO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
PSO has no meaningful PE right now: it lost money over the past year.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 69% below its 200-week average.
PSO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.2 | 0.2% above |
| 20 week MA | $16.7 | 3.1% above |
| 50 week MA | $15.0 | 15% above |
| 100 week MA | $15.1 | 14% above |
| 200 week MA | $13.6 | 27% above |
PSO has the edge over AMC on trend strength, trading above more of its moving averages.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over PSO on returns for 2026, with the stronger performance.
PSO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.49 | $9.21 | +8.5% |
| 2021 | $9.21 | $8.19 | -11% |
| 2022 | $8.19 | $11.3 | +37% |
| 2023 | $11.3 | $12.3 | +9.2% |
| 2024 | $12.3 | $16.2 | +32% |
| 2025 | $16.2 | $14.2 | -12% |
| 2026 YTD | $14.2 | $17.2 | +21% |
PSO has finished higher in four of the last six years. It's up 21% so far in 2026.